Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460237 · ClinicalTrials.gov registry record · NA
HPV Self-Test Intervention in Ohio Appalachia
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT02460237 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 103 participants.
The verdict
NCT02460237, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
This study will pilot test a culturally appropriate human papillomavirus (HPV) self-test intervention among women from Ohio Appalachia in order to determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy. The intervention group will receive culturally appropriate materials and the control group will receive standard materials with their HPV self-test device.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Survey Administration
- OTHER Educational Intervention
- OTHER Informational Intervention
- PROCEDURE Disease Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460237
The ClinicalTrials.gov registry entry for NCT02460237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02460237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460237 about?
NCT02460237 is a clinical study titled "HPV Self-Test Intervention in Ohio Appalachia". This study will pilot test a culturally appropriate human papillomavirus (HPV) self-test intervention among women from Ohio Appalachia in order to determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy. The intervention group will receive culturally appropria...
What is the current status of trial NCT02460237?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2015-11. Estimated completion is 2017-03-15.
What interventions are being tested in trial NCT02460237?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Survey Administration (OTHER), Educational Intervention (OTHER), Informational Intervention (OTHER), Disease Screening (PROCEDURE).
Who is sponsoring clinical trial NCT02460237?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.